期刊文献+

老年患者多重用药合理方案的制定 被引量:5

Development of reasonable solution of polypharmacy for the elderly patients
下载PDF
导出
摘要 全球老龄化时代已到来,老年人健康问题已成为全球焦点。老年人常患有多种疾病,多重用药不可避免。多项研究显示,老年患者用药存在许多潜在不恰当的现象,加之药物本身存在的不良反应及药物之间的相互作用产生的不良反应,给老年患者造成严重伤害。因此,发现、筛查不恰当用药的方法,制定合理用药方案,减少老年人由于多重用药导致的不良反应的发生就显得尤为重要。 With the advent of the era of global aging, the health issues of the elderly people have become a global focus. Elderly people with numerous diseases are unavoidable to require several medications to treat their diseases. Many studies have shown that there are potentially inappropriate medications (PIM), and in addition, adverse drug effects resulting from the adverse drug reaction and drug-drug interactions, which impose a great harmful effect to elderly patients. Thus, it is important to develop some strategies to identify potentially inappropriate medications and establish some interventions so as to improve the appropriate medication and reduce the risk of adverse health events caused by polypharmacy.
出处 《上海医药》 CAS 2014年第19期61-63,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 多重用药 老年人 不良反应 合理用药 polypharmacy elderly people adverse drug effects appropriate medication
  • 相关文献

参考文献13

  • 1郑秋甫.老年人合理用药(一)[J].中华保健医学杂志,2011,13(4):355-356. 被引量:8
  • 2Blozik E, Rapold R, von Overbeck J, et al. Polypharmacy and potentially inappropriate medication in the adult, community- dwelling population in Switzerland [J]. Drugs Aging, 2013, 30(7): 561-568.
  • 3Umemura K, Furuta T, Kondo K. The common gene variants of CYP2C 19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects [J]. J Thromb Haemost, 2008, 6(8): 1439-1441.
  • 4D'Andrea G, D'Ambrosio RL, DiPerna P, et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin [J]. Blood, 2005, 105(2): 645-649.
  • 5Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC 1 cause warfarin resistance and multiple coagulation factor deficiency type 2 [J]. Nature, 2004, 427(6974): 537-541.
  • 6Klein TE, Altman RB, Eriksson N, et al. Estimation of the warfarin dose with clinical and pharmacogenetic data [J]. N Engl J Med, 2009, 360(8): 753-764.
  • 7王烨,李影影,蔡郁.Beers标准回顾性评价老年住院患者存在的潜在不适当用药[J].实用药物与临床,2013,16(9):874-875. 被引量:19
  • 8沈杰,刘奕芳,高宁舟,宋钟娟.Beers判断标准在老年住院患者潜在性不适当用药评价中的应用[J].中国药房,2010,21(6):556-558. 被引量:53
  • 9Hill-Taylor B, Sketris I, Hayden J, et al. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact [J]. J Clin Pharm Ther, 2013, 38(5): 360-372.
  • 10Ryan C, O'Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in an Irish elderly population in primary care [J]. Br J Clin Pharmacol, 2009, 68(6): 936-947.

二级参考文献18

  • 1陆丽珠.草药的安全性与管理[J].药物不良反应杂志,2004,6(6):387-392. 被引量:11
  • 2Gallagher P, Barry P, O' Mahony D. Inappropriate pre- scribing in the elderly[J]. J Clin Pharm Ther, 2007, 32 (2):113.
  • 3Fick DM, Cooper JW, Wade WE, et al.Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts[J]. Arch lntern Meal,2003,163(22) :2 716.
  • 4Rancourt C, Moisan J, Baillargeon L, et al.Potentially inappropriate prescriptions for older patients in long-term care [J]. BMC Geriatr, 2004,4( 1 ) : 9.
  • 5Chang CM, Liu PY, Yang YH, et al. Potentially inappro- priate drug prescribing among first-visit elderly outpatients in Taiwan [J]. Pharmacotherapy, 2004, 24 (7) :848.
  • 6Onder G, Landi F, Cesari M, et al. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly[J]. Eur J Clin Pharmacol, 2003,59 ( 2 ) : 157.
  • 7Viswanathan H, Bharmal M, Thomas J. Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001 : comparison of three explicit criteria[J]. Clin Ther, 2005,27( 1 ) : 88.
  • 8徐江红,张静,吴骏,李先飞,李文.门、急诊处方基本指标调查与用药分析[J].中国药房,2007,18(35):2750-2753. 被引量:21
  • 9曹春柳,刘文二.二羟丙茶碱致失眠1例报告[J].中国乡村医药,2008,15(6):46-46. 被引量:2
  • 10刘皈阳,魏宇宁,董圣惠,曹倩,张静.我院门诊处方评价方法及其结果分析[J].中国药房,2008,19(16):1262-1264. 被引量:41

共引文献70

同被引文献79

  • 1O'Mahony D,Gallagher P,Ryan C,et al.STOPP&START criteria:a new approach to detecting potentially inappropriate prescribing in old age[J].Eur Geriatr M ed,2010,1(1):45-51.
  • 2Blanco-Reina E,Ariza-Zafra G,Ocaa-Riola R,et al.2012 American Geriatrics Society Beers Criteria:enhanced applicability for detecting potentially inappropriate medications in European older adults?A comparison w ith the Screening Tool of Older Person's Potentially Inappropriate Prescriptions[J].J Am Geriatr Soc,2014,62(7):1217-1223.
  • 3Hill-Taylor B,Sketris I,Hayden J,et al.Application of the STOPP/START criteria:a systematic review of the prevalence of potentially inappropriate prescribing in older adults,and evidence of clinical,humanistic and economic impact[J].J Clin Pharm Ther,2013,38(5):360-372.
  • 4Ubeda A,Ferrándiz L,Maicas N,et al.Potentially inappropriate prescribing in institutionalised older patients in Spain:the STOPP-START criteria compared w ith the Beers criteria[J].Pharm Pract(Granada),2012,10(2):83-91.
  • 5Fialovd D,Topinkova E,Gambassi G,et al.Potentially inappropriate medication use among elderly home care patients in Europe[J].JAM A,2005,293(11):1348-1358.
  • 6许卫华,王奇,梁伟雄.慢性疾病患者服药依从性测量量表的编制[J].中国慢性病预防与控制,2008,16(6):558-560. 被引量:95
  • 7杨华,魏晶,王嘉仡,刘巍,金少鸿.药品不良反应/事件报告评价方法研究[J].中国药物警戒,2009,6(10):581-584. 被引量:114
  • 8沈杰,刘奕芳,高宁舟,宋钟娟.Beers判断标准在老年住院患者潜在性不适当用药评价中的应用[J].中国药房,2010,21(6):556-558. 被引量:53
  • 9李海英,李春平.浅谈干休所药学服务[J].中华保健医学杂志,2011,13(3):224-224. 被引量:2
  • 10石秀锦,蔡郁,陈峥.老年患者多重用药现状及研究进展[J].中国临床医生杂志,2011,39(8):29-31. 被引量:21

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部